BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.68
+1.51 (4.42%)
At close: May 12, 2025, 4:00 PM
35.00
-0.68 (-1.91%)
After-hours: May 12, 2025, 7:33 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $6.77 billion as of May 12, 2025. Its market cap has increased by 46.74% in one year.
Market Cap
6.77B
Enterprise Value
8.09B
1-Year Change
46.74%
Ranking
Category
Stock Price
$35.68
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $6.77B, an increase of 104.08%. That is a compound annual growth rate of 12.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.63B |
| Johnson & Johnson | 371.43B |
| UnitedHealth Group | 343.70B |
| AbbVie | 337.44B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |